Airgain Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Airgain, Inc. on November 7, 2016. The report discloses a corporate governance event regarding the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Joan Gillman to the Board of Directors, effective November 7, 2016. Ms. Gillman was appointed as a Class III director with a term expiring at the 2019 annual meeting. She was assigned to the audit, compensation, and nominating and corporate governance committees. Consequently, she replaced Francis X. Egan on the compensation committee, Frances Kordyback on the audit committee, and Charles Myers on the nominating and corporate governance committee.
Compensation and Governance Details
- Equity Grant: Ms. Gillman received an option to purchase 10,000 shares of common stock at an exercise price of $12.11 per share, equal to the fair market value on the grant date.
- Vesting Schedule: The option vests in substantially equal installments over three years, contingent on continued service.
- Cash Compensation: Ms. Gillman will receive cash compensation for board and committee service in accordance with the Company's non-employee director compensation program.
- Independence: The Board determined Ms. Gillman meets NASDAQ independence requirements.
Outlook and Risks
The filing text does not provide a clear value for future guidance, management outlook, or specific risk factors beyond standard governance disclosures. No unusual items or contingencies were reported in this document.
Key Facts for Investor Verification
- Verify the impact of the new board composition on the Company's strategic direction and oversight.
- Confirm the total cash and equity compensation costs associated with the new director appointment.
- Review the Company's non-employee director compensation program details referenced in the Form S-1 Registration Statement.
- Monitor the vesting schedule and potential dilution from the 10,000 share option grant.